SCHEMBL13532547

SCHEMBL13532547

CCCCO[C@@H]1[C@@H](CO)O[C@@](CO)(c2ccc3c(N)ncnn23)[C@]1(C)OCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12454576 0.92 — —
SCHEMBL13532037 0.84 TNK2 (0.33) —
SCHEMBL13532503 0.82 ADORA2A (0.30) —
SCHEMBL15084442 0.82 — —
SCHEMBL12454575 0.82 — —
SCHEMBL12454577 0.78 — —
SCHEMBL12295266 0.78 — —
SCHEMBL12393386 0.77 HSPA5 (0.35) —
SCHEMBL12393365 0.77 ADORA2A (0.37) —
SCHEMBL12454580 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100021425-A1 1'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT GILEAD SCIENCES, INC. (US) 2010-01-28 — — US disclosed
Send feedback